Clinical Trials on High Risk Smoldering Multiple Myeloma
Total 3936 results
-
Abiomed Inc.Active, not recruitingHigh-risk Percutaneous Coronary InterventionUnited States
-
Magenta Medical Ltd.Active, not recruitingHigh-Risk Percutaneous Coronary InterventionGeorgia
-
Etlik Zubeyde Hanım Women's Health Care, Training...CompletedCervical Ripening | Pregnancy, High-RiskTurkey
-
Recep Tayyip Erdogan University Training and Research...CompletedHigh Caries Risk | Low Caries RiskTurkey
-
Edwards LifesciencesRecruiting
-
Oslo University HospitalTargovax ASARecruitingMultiple Myeloma | Smoldering Multiple MyelomaNorway
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Multiple Myeloma Research Consortium; Blood Cancer Research...CompletedSmoldering Multiple MyelomaUnited States
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States
-
Massachusetts General HospitalCelgene; OncoPep, Inc.Active, not recruitingSmoldering Multiple MyelomaUnited States
-
Intergroupe Francophone du MyelomeActive, not recruitingSmoldering Multiple MyelomaFrance, Belgium, Monaco
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
National Cancer Institute (NCI)WithdrawnMultiple Myeloma
-
OncoPep, Inc.CompletedSmoldering Multiple MyelomaUnited States
-
Meir Medical CenterWithdrawnSmoldering Multiple Myeloma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Blasts 20 Percent or More of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk...United States
-
Stichting European Myeloma NetworkJanssen, LPRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | Plasma Cell Leukemia | MGUS | Extramedullary MyelomaItaly, Austria, Czechia, Greece, Serbia
-
Cairo UniversityCompletedHigh Caries Risk Patients | Streptococcus MutansEgypt
-
University of ChicagoNorthwestern University; University of Illinois at Chicago; Rush University Medical... and other collaboratorsActive, not recruitingMedicare Patients | High Risk of HospitalizationsUnited States
-
Tver Regional Perinatal CenterCompletedObstetric Anesthesia Problems | High-Risk PregnancyRussian Federation
-
Memorial Sloan Kettering Cancer CenterCompletedHigh Risk for Postoperative Cardiovascular EventsUnited States
-
European Myeloma NetworkPfizerNot yet recruitingSmoldering Multiple MyelomaNetherlands, Finland, Norway, France, Italy, Greece
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
University of RochesterAmgenActive, not recruiting
-
BioInvent International ABTerminated
-
Lene Meldgaard KnudsenIO BiotechTerminatedSmoldering Multiple MyelomaDenmark
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
PETHEMA FoundationCelgene CorporationCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Women's College HospitalHealth Quality OntarioCompletedHigh-risk Prescribing in Nursing HomesCanada
-
Birmingham Women's NHS Foundation TrustGE Healthcare; Nestmedic S.A.Not yet recruitingPregnancy, High Risk | Telemedicine | Ultrasound | Cardiotocography | Telemonitoring
-
Johann Wolfgang Goethe University HospitalTerminatedMalignant and Non-malignant High Risk DiseasesGermany
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
Queens College, The City University of New YorkState University of New York at BuffaloTerminatedParenting | Prevention | Child Maltreatment | Fathers | High-riskUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
VA Office of Research and DevelopmentRecruitingOlder Men and Women With High Fall RiskUnited States
-
Queen's University, BelfastCompletedPatients at High Risk of Medicine-related ProblemsUnited Kingdom
-
Izmir University of EconomicsCompleted
-
Cairo UniversityUnknownClass I Cavities in High Caries RiskEgypt
-
Philipps University Marburg Medical CenterKerckhoff Heart CenterCompletedHemodynamic Instability During Anesthesia | High Risk SurgeryGermany
-
GWT-TUD GmbHAmsterdam UMC, location VUmc; BerGenBio ASA; Groupe Francophone des MyelodysplasiesCompletedAcute Myeloid Leukemia | High-risk Myelodysplastic Syndrome | Low-risk Myelodysplastic SyndromeGermany, Netherlands, France
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....Not yet recruitingHigh-risk (Secondary) Acute Myeloid LeukemiaChina